Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sarilumab vs Adalimumab Monotherapy in RA (MONARCH)
NCT02332590Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jan 2015
- Primary completion
- Jan 2016
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 15
01
Overview
A Phase 3 trial of sarilumab in rheumatoid arthritis (RA), sponsored by Sanofi. Started Jan 2015; status: completed.
02
Drugs
sarilumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02332590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02332590.